[1]
L. Ferrario, “Optimization in the HIV treatment: economic and organizational impact analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide”, Grhta, vol. 12, no. 1, pp. 49–60, Feb. 2025.